Cargando…
The effects of acarbose treatment on cardiovascular risk factors in impaired glucose tolerance and diabetic patients: a systematic review and dose–response meta-analysis of randomized clinical trials
Acarbose (ACB) seems to be an effective drug in the management of cardiovascular risk factors. However, no previous meta-analysis of randomized controlled trials (RCTs) has been done to evaluate the effects of ACB on cardiovascular risk factors on impaired glucose tolerance (IGT), type 2 diabetes me...
Autores principales: | Zamani, Mohammad, Nikbaf-Shandiz, Mahlagha, Aali, Yasaman, Rasaei, Niloufar, Zarei, Mahtab, Shiraseb, Farideh, Asbaghi, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433190/ https://www.ncbi.nlm.nih.gov/pubmed/37599681 http://dx.doi.org/10.3389/fnut.2023.1084084 |
Ejemplares similares
-
The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
por: Zamani, Mohammad, et al.
Publicado: (2022) -
The effects of L-carnitine supplementation on glycemic markers in adults: A systematic review and dose-response meta-analysis
por: Zamani, Mohammad, et al.
Publicado: (2023) -
The effects of saffron supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis
por: Zamani, Mohammad, et al.
Publicado: (2022) -
The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials
por: Yousefi, Mohsen, et al.
Publicado: (2023) -
The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose–response meta-analysis
por: Khorasanian, Atie Sadat, et al.
Publicado: (2023)